Plain-English translation of NCT06535568 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a new approach to managing blood clotting after a heart procedure called percutaneous coronary intervention (PCI) with a drug-coated balloon. The trial compares two strategies: taking just one blood-thinning medication (like aspirin alone) versus taking two blood-thinning medications together. The goal is to see if the single-medication approach works just as well while reducing the risk of bleeding in older patients and those who are prone to bleeding.
People who receive heart procedures typically must take two blood-thinning pills to prevent blood clots, but this increases the risk of serious bleeding—especially for elderly patients and those with other health conditions. Researchers want to know if one medication is enough when using this newer type of balloon, which could make treatment safer and easier to manage.
You likely qualify if…
You likely don't qualify if…
After your heart procedure with the drug-coated balloon, you will be randomly assigned to take either one or two blood-thinning medications. You will then be followed over time with visits and tests to monitor how well the treatment works and whether you experience any bleeding or other complications. The study will track your health outcomes to compare the safety and effectiveness of the single-medication approach versus the standard two-medication approach.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Italy